Jul 2026
Molecular Docking and Pharmacological In Silico Evaluation of Genistein and Hematoxylin as Promising Ribonucleotide Reductase-targeted Therapies for Cancer.
Genistein and hematoxylin demonstrate promising molecular interactions and pharmacological profiles as potential natural RR inhibitors and supports further preclinical development as anticancer agents.
Oun Deli Khudhair, Muhammad Azrul Zabidi, A. M. Gazzali et al.
· Current Computer - Aided Dru... · 0 citations